Cefotiam(CAS: 61622-34-2)

Cefotiam (CAS: 61622-34-2) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a pharmaceutical agent. It must comply with REACH regulations in the EU, which require manufacturers and importers to register chemicals and provide safety data sheets. In the US, it is subject to FDA requirements for pharmaceuticals and must conform to EPA guidelines for the handling and disposal of hazardous substances.

There are several alternatives to Cefotiam (CAS: 61622-34-2) in synthesis, including cephalosporins like cefuroxime and ceftriaxone. These alternatives can serve similar antibacterial purposes and are often used in clinical settings as substitutes depending on the specific infection and patient needs. Common alternative reagents include different β-lactam antibiotics with varying antibiotic spectra.

Cefotiam (CAS: 61622-34-2) is a key antibacterial agent in the cephalosporin class, and its market trend reflects the ongoing need for effective antibiotics against resistant bacterial strains. Research trends focus on developing new cephalosporins with broader or more targeted spectra. Market dynamics show a steady demand with occasional fluctuations based on the emergence of resistant pathogens and changes in healthcare policies.

Waste containing Cefotiam (CAS: 61622-34-2) should be collected in appropriate containers and labeled as hazardous. Proper incineration or professional waste disposal services should be utilized to ensure safe disposal. Environmental protection measures include minimizing contamination of soil and water, and following local regulations for the disposal of pharmaceutical waste. Safety precautions should be observed to prevent exposure and ensure the waste is handled by trained professionals.